Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers

Research output: Contribution to journalBook/Film/Article review

11 Citations (Scopus)

Abstract

Severe sepsis is a major healthcare problem and the early initiation of antimicrobials is one of the few measures associated with improved outcomes. However, antibiotic overuse is an increasing problem in critical care. Of several potential biomarkers for antibiotic stewardship, procalcitonin represents the most widely studied and validated. In this commentary we address the current literature on the use of biomarkers to guide antimicrobial therapy in the critically ill and discuss its limitations and future directions.
Original languageEnglish
Pages (from-to)142-142
JournalCritical Care
Volume18
Issue number3
DOIs
Publication statusPublished - 1 Jan 2014

Fingerprint

Calcitonin
Sepsis
Biomarkers
Anti-Bacterial Agents
Critical Care
Critical Illness
Delivery of Health Care
Therapeutics
Direction compound

Cite this

@article{5bdfb9a577fb430e8daef32946b9f5a2,
title = "Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers",
abstract = "Severe sepsis is a major healthcare problem and the early initiation of antimicrobials is one of the few measures associated with improved outcomes. However, antibiotic overuse is an increasing problem in critical care. Of several potential biomarkers for antibiotic stewardship, procalcitonin represents the most widely studied and validated. In this commentary we address the current literature on the use of biomarkers to guide antimicrobial therapy in the critically ill and discuss its limitations and future directions.",
keywords = "Medicine, Critical, Care",
author = "Pedro P{\'o}voa",
note = "PMID:25032999 WOS:000341163800056",
year = "2014",
month = "1",
day = "1",
doi = "10.1186/cc13870",
language = "English",
volume = "18",
pages = "142--142",
journal = "Critical Care",
issn = "1364-8535",
publisher = "BIOMED CENTRAL LTD",
number = "3",

}

Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers. / Póvoa, Pedro .

In: Critical Care, Vol. 18, No. 3, 01.01.2014, p. 142-142.

Research output: Contribution to journalBook/Film/Article review

TY - JOUR

T1 - Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers

AU - Póvoa, Pedro

N1 - PMID:25032999 WOS:000341163800056

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Severe sepsis is a major healthcare problem and the early initiation of antimicrobials is one of the few measures associated with improved outcomes. However, antibiotic overuse is an increasing problem in critical care. Of several potential biomarkers for antibiotic stewardship, procalcitonin represents the most widely studied and validated. In this commentary we address the current literature on the use of biomarkers to guide antimicrobial therapy in the critically ill and discuss its limitations and future directions.

AB - Severe sepsis is a major healthcare problem and the early initiation of antimicrobials is one of the few measures associated with improved outcomes. However, antibiotic overuse is an increasing problem in critical care. Of several potential biomarkers for antibiotic stewardship, procalcitonin represents the most widely studied and validated. In this commentary we address the current literature on the use of biomarkers to guide antimicrobial therapy in the critically ill and discuss its limitations and future directions.

KW - Medicine

KW - Critical

KW - Care

U2 - 10.1186/cc13870

DO - 10.1186/cc13870

M3 - Book/Film/Article review

VL - 18

SP - 142

EP - 142

JO - Critical Care

JF - Critical Care

SN - 1364-8535

IS - 3

ER -